| Relevance of the Concept of Oncogene Addiction to Hormonal Carcinogenesis and Molecular Targeting in Cancer Prevention and Therapy | p. 3 |
| What Can we Learn about Breast Cancer from Stem Cells? | p. 17 |
| Ovarian Cancer: Linking Genomics to New Target Discovery and Molecular Markers - The Way Ahead | p. 23 |
| Cdk1, Plks, Auroras, and Neks: The Mitotic Bodyguards | p. 41 |
| Women's Health Research: Perspectives from the National Institutes of Health | p. 57 |
| Stem Cells, Hormones, and Mammary Cancer | p. 69 |
| The Origin of Estrogen Receptor [alpha]-Positive and [alpha]-Negative Breast Cancer | p. 79 |
| Hormone Refractory Prostate Cancer: Lessons Learned from the PTEN Prostate Cancer Model | p. 87 |
| Functional Significance of Aurora Kinase A in Centrosome Amplification and Genomic Instability | p. 99 |
| Centrosome-Mediated Chromosomal Instability and Steroid Hormones as Co factors in Human Papillomavirus-Associated Cervical Carcinogenesis: Small Viruses Help to Answer Big Questions | p. 109 |
| Regulation of Hormone Signaling by Nuclear Receptor Interacting Proteins | p. 121 |
| Dynamics of Estrogen Receptor-mediated Transcriptional Activation of Responsive Genes In Vivo: Apprehending Transcription in Four Dimensions | p. 129 |
| Expression of Estrogen Receptors [alpha] and [beta] in Early Steps of Human Breast Carcinogenesis | p. 139 |
| Women's Health Initiative Studies of Postmenopausal Breast Cancer | p. 151 |
| Circulating Levels of Sex Steroids and Prolactin in Premenopausal Women and Risk of Breast Cancer | p. 161 |
| Ovulation and Ovarian Cancer | p. 171 |
| Prostate Cancer Susceptibility Loci: Finding the Genes | p. 179 |
| Strategy for the Application of Therapy in Prostate Cancer | p. 193 |
| Response and Resistance to the Endocrine Prevention of Breast Cancer | p. 201 |
| Estrogen-Induced Breast Oncogenesis: Modulation by an Aurora Kinase Inhibitor | p. 213 |
| Castration-Recurrent Prostate Cancer Is Not Androgen-Independent | p. 223 |
| Estrogen-Receptor-Related Receptors and Hormone-Dependent Cancers | p. 235 |
| Androgen Receptor Coactivators and Prostate Cancer | p. 245 |
| Why Hormones Protect Against Large Bowel Cancer: Old Ideas, New Evidence | p. 259 |
| Vitamin D[subscript 3] and Colorectal Cancer | p. 271 |
| Estrogen-Signaling Pathways in Lung Cancer | p. 281 |
| Noninvasive Measurement of the Electrical Properties of Breast Epithelium During the Menstrual Cycle: A Potential Biomarker for Breast Cancer Risk | p. 297 |
| Is the Mannose-6-Phosphate/Insulin-Like Growth Factor 2 Receptor Coded by a Breast Cancer Suppressor Gene? | p. 305 |
| Her-2/neu-induced "Cytokine Signature" in Breast Cancer | p. 311 |
| Involvement of a JAK/STAT Pathway Inhibitor: Cytokine Inducible SH2 Containing Protein in Breast Cancer | p. 321 |
| In Silico and In Vitro Analysis of Small Breast Epithelial Mucin as a Marker for Bone Marrow Micrometastasis in Breast Cancer | p. 331 |
| Estrogen-regulated Cut-off Values of pS2 and Cathepsin D Expression in Breast Carcinomas | p. 341 |
| Molecular Signatures of Estrogen Receptor-Associated Genes in Breast Cancer Predict Clinical Outcome | p. 349 |
| Comparative Analysis of SNP in Estrogen-metabolizing Enzymes for Ovarian, Endometrial, and Breast Cancers in Novosibirsk, Russia | p. 359 |
| IRF-1 Promotes Apoptosis in p53-damaged Basal-type Human Mammary Epithelial Cells: A Model for Early Basal-type Mammary Carcinogenesis | p. 367 |
| Steroid Receptor and Growth Factor Receptor Expression in Human Nonsmall Cell Lung Cancers Using Cells Procured by Laser-capture Microdissection | p. 377 |
| Blood Levels of Organochlorine Pesticide Residues and Risk of Reproductive Tract Cancer Among Women from Jaipur, India | p. 387 |
| AKT Regulates Androgen Receptor-dependent Growth and PSA Expression in Prostate Cancer | p. 397 |
| Expression of Selected Aurora A Kinase Substrates in Solely Estrogen-induced Ectopic Uterine Stem Cell Tumors in the Syrian Hamster Kidney | p. 411 |
| Global Quantitative Analysis of Protein Phosphorylation Status in Fish Exposed to Microcystin | p. 419 |
| ERK/MAPK Regulation of the Androgen Responsiveness of Breast Cancer Cells | p. 429 |
| Vascular Endothelial Growth Factor is a Target Gene for Estrogen Receptor and Contributes to Breast Cancer Progression | p. 437 |
| Identification of Downstream Targets of Estrogen and c-myc in Breast Cancer Cells | p. 445 |
| Cathepsin D Overexpressed by Cancer Cells Can Enhance Apoptosis-dependent Chemo-sensitivity Independently of Its Catalytic Activity | p. 453 |
| A Synthetic Peptide Derived from Alpha-fetoprotein Inhibits the Estradiol-induced Proliferation of Mammary Tumor Cells in Culture through the Modulation of p21 | p. 463 |
| Hormonal Prevention of Breast Cancer: Significance of Promotional Environment | p. 469 |
| Hormones of Pregnancy, [alpha]-Feto Protein, and Reduction of Breast Cancer Risk | p. 477 |
| Role of Estrogens and Their Receptors in Adhesion and Invasiveness of Breast Cancer Cells | p. 485 |
| Proteomic Analysis of Autocrine/Paracrine Effects of Human Growth Hormone in Human Mammary Carcinoma Cells | p. 493 |
| Expression Analysis of Human Endometrial Adenocarcinoma in an Inbred Rat Model | p. 503 |
| Amplification Studies of MET and Cdk6 in a Rat Endometrial Tumor Model and Their Correlation to Human Type I Endometrial Carcinoma Tumors | p. 511 |
| Recurrent Chromosome 10 Aberrations and Tp53 Mutations in Rat Endometrial Adenocarcinomas | p. 519 |
| Specific Properties of a C-terminal Truncated Androgen Receptor Detected in Hormone Refractory Prostate Cancer | p. 529 |
| The Role of the Transcriptional Coactivator p300 in Prostate Cancer Progression | p. 535 |
| Characterization of Androgen Regulation of ZEB-1 and PSA in 22RV1 Prostate Cancer Cells | p. 541 |
| Mcl-1 is Regulated by EL-6 and Mediates the Survival Activity of the Cytokine in a Model of Late Stage Prostate Carcinoma | p. 547 |
| Sex Hormone-binding Globulin Influences Gene Expression of LNCaP and MCF-7 Cells in Response to Androgen and Estrogen Treatment | p. 557 |
| Inactivation of ID-1 Gene Induces Sensitivity of Prostate Cancer Cells to Chemotherapeutic Drugs | p. 565 |
| Membrane Initiated Signaling by 1,25[alpha]-dihydroxyvitamin D[subscript 3] in LNCaP Prostate Cancer Cells | p. 573 |
| Gonadotrophin Releasing Hormone-Based Vaccine, an Effective Candidate for Prostate Cancer and Other Hormone-sensitive Neoplasms | p. 581 |
| Pigment Epithelium-derived Factor is an Angiogenesis and Lipid Regulator that Activates Peroxisome Proliferator-activated Receptor [alpha] | p. 591 |
| Estrogenic Activity of the Equine Estrogen Metabolite, 4-Methoxyequilenin | p. 601 |
| Dynamics of Oxidative Damage at Early Stages of Estrogen-dependant Carcinogenesis | p. 609 |
| Gene Expression of 17[beta]-Estradiol-metabolizing Isozymes: Comparison of Normal Human Mammary Gland to Normal Human Liver and to Cultured Human Breast Adenocarcinoma Cells | p. 617 |
| Phytoestrogens Modulate the Expression of 17[alpha]-Estradiol Metabolizing Enzymes in Cultured MCF-7 Cells | p. 625 |
| Index | p. 633 |
| Table of Contents provided by Blackwell. All Rights Reserved. |
